L
LCTX
Lineage Cell The
1.290
-0.010-0.77%Pre Market: 1.300 +0.010 +0.79%08:34 05/27 EDT
OPEN/PREV CLOSE1.300/1.300
TODAY RANGE1.270-1.340
VOL1.82K
MARKET CAP321.59M
52 WEEK RANGE0.6400-2.090
AVG VOL (3M)1.25M
% TURNOVER0.49%
TURNOVER0
P/E (TTM)-4.6154
% RANGE5.38%
EPS(TTM)-0.2795
P/E(FORWARD)-21.5000
P/B5.97
BVPS0.2161
DIVIDEND--
P/S21.54
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP305.74M
SHARES OUTSTANDING249.30M
NEXT EARNINGS08/10-08/14
FREE FLOAT237.01M
LOT SIZE1
EX-DATE11/29/2018
News
Press Releases
Financial Reports
Profile
TipRanks·05/14 00:12
Lineage Cell Therapeutics Highlights R&D Momentum Amid Losses
TipRanks·05/13 11:21
Canaccord Genuity Reaffirms Their Buy Rating on Lineage Therap (LCTX)
Seeking Alpha·05/13 01:52
Lineage targets operations into Q2 2028 as it launches COR1 and scales ILT1 manufacturing
TipRanks·05/12 22:11
Lineage Cell Therapeutics reports Q1 EPS (3c), consensus (2c)
TipRanks·05/12 22:10
Lineage Cell sees cash, equivalents funding operations into 2Q28
Seeking Alpha·05/12 20:03
Lineage Cell Therapeutics GAAP EPS of -$0.03 misses by $0.01, revenue of $1.72M misses by $1.36M
Dow Jones·05/12 20:02
*Lineage Cell Therapeutics 1Q Loss/Shr 3c >LCTX
Dow Jones·05/12 20:02
*Lineage Cell Therapeutics 1Q Rev $1.73M >LCTX
Dow Jones·05/12 20:01
Press Release: Lineage Cell Therapeutics Reports -2-
Seeking Alpha·05/12 14:00
Here are the major earnings after the close Tuesday